PHARMA PLUS
ActiveSummary
PHARMA PLUS has been active since 1987 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €876,038 and a net result of €15,884. Equity remains stable across the filed financial years (±1.6% per year). Its solvency ranks better than 92% of 4,937 sector peers (NACE 47, financial year 2025). The computed 12-month bankruptcy probability is 0.2% (very low).
History
Acts, filings and financial milestones
Next filing, financial year 2026, expected by
2026
04-08
Gazette deed
Resignation: SRL ALEXO (director)Appointment: SRL KST Pharma (director) · Permanent representative: Koen Straetmans · Reappointment: SRL SODIAP (managing director)6 facts ▸
Gazette deed
Resignation: SRL ALEXO (director)
Appointment: SRL KST Pharma (director) · Permanent representative: Koen Straetmans · Reappointment: SRL SODIAP (managing director)6 facts ▸
- General meeting, 19-05-2026
- Director resignation, SRL ALEXO (director)
- Director appointment, SRL KST Pharma (director)
- Permanent representative, Koen Straetmans
- Board meeting, 19-05-2026
- Director reappointment, SRL SODIAP (managing director)
12-05
NBB filing
Annual accounts filed
financial year 2025 · full format
2025
17-06
NBB filing
Annual accounts filed
financial year 2024 · full format
2024
31-12
Financial
Liquidity more than doubledcurrent ratio 4.31
Current ratio from 1.86 to 4.31; short-term debt falls from €296,324 to €189,118.
12-06
NBB filing
Annual accounts filed
financial year 2023 · full format
2023
09-06
NBB filing
Annual accounts filed
financial year 2022 · full format
2022
31-12
Financial
Highest result from 2018 to 2025net €92,689 ▲68.9%
Net result €92,689, the highest in the series.
07-06
NBB filing
Annual accounts filed
financial year 2021 · full format
2021
31-12
Financial
Back to profitnet €54,870
Net result €54,870 after one loss-making year.
31-12
Financial
Equity above €1mequity €1.0m ▲5.8%
Equity rises from €951,305 to €1.0m.
14-06
NBB filing
Annual accounts filed
financial year 2020 · full format
2020
31-12
Financial
Weakest financial yearnet -€29,963
Net result drops to -€29,963, the lowest in the series; recovery starts the following year.
Show earlier events
31-12
Financial
Liquidity more than doubledcurrent ratio 2.46
Current ratio from 1.12 to 2.46; short-term debt falls from €377,402 to €182,917.
14-07
NBB filing
Annual accounts filed
financial year 2019 · full format
2019
09-07
NBB filing
Annual accounts filed
financial year 2018 · full format
2018
28-06
NBB filing
Annual accounts filed
financial year 2017 · full format
2017
10-07
NBB filing
Annual accounts filed
financial year 2016 · abbreviated format
Financial milestoneGazette deedNBB filingFinancial milestones sit on the financial year-end date, not the filing date.Of the 38 annual accounts filed, the latest 10 are here; all 38 are under Financials.
1 of 8 deeds read
About the unread acts
Of the 8 Belgian Official Gazette deeds we know for this company, 1 has been read. The other 7 have not been read yet: what they contain is neither established nor disproved here.
Have them read with priority
Sign in to place this company at the front of the reading queue.